ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,958.25
0.46%
US Tech 100
20,858.69
0.54%
다우존스 지수
42,812.23
-0.07%
Bitcoin
93,500.00
-1.69%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. MoonLake Immunotherapeutics (MLTX) 시세

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics (MLTX)

NASDAQ
52.81
0.64
( 1.23% )
업데이트: 02:58:53
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
52.81
매수가
52.67
매도가
52.89
거래량
37,005
51.51 일간 변동폭 52.95
37.55 52주 범위 64.98
market_cap
3.375B
전일 종가
52.17
개장가
52.12
최근 거래 시간
47
@
52.805
마지막 거래 시간
03:00:18
재정 규모
US$ 1,938,963
VWAP
52.3973
평균 볼륨(3m)
277,416
발행 주식
63,905,198
배당수익률
-
주가수익률
-76.43
주당순이익(EPS)
-0.69
매출
-
순이익
-44.08M

MoonLake Immunotherapeutics 정보

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

섹터
Blank Checks
산업
Pharmaceutical Preparations
웹사이트
moonlaketx.com
본부
Grand Cayman, Cym
설립됨
2020
MoonLake Immunotherapeutics is listed in the Blank Checks sector of the 나스닥 with ticker MLTX. The last closing price for MoonLake Immunotherapeut... was US$52.17. Over the last year, MoonLake Immunotherapeut... shares have traded in a share price range of US$ 37.55 to US$ 64.98.

MoonLake Immunotherapeut... currently has 63,905,198 shares in issue. The market capitalisation of MoonLake Immunotherapeut... is US$3.33 billion. MoonLake Immunotherapeut... has a price to earnings ratio (PE ratio) of -76.43.

MLTX 최신 뉴스

추가 뉴스

Form 8-K - Current report

19 12월 2024
Edgar (US Regulatory)

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis Two trials for active psoriatic arthritis (PsA) with one focusing...

13 11월 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

07 11월 2024
Edgar (US Regulatory)

Form 8-K - Current report

07 11월 2024
Edgar (US Regulatory)

MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update

MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update Ended the third quarter with $493.9 million in cash, cash equivalents and short-term...

07 11월 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

09 10월 2024
Edgar (US Regulatory)

Form 8-K - Current report

11 9월 2024
Edgar (US Regulatory)

MoonLake Immunotherapeutics to host a Capital Markets Update on Wednesday, September 11

MoonLake Immunotherapeutics to host a Capital Markets Updateon Wednesday, September 11 ZUG, Switzerland, September 9, 2024 – MoonLake Immunotherapeutics AG (“MoonLake”; Nasdaq: MLTX), a...

09 9월 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

07 8월 2024
Edgar (US Regulatory)

Form 8-K - Current report

07 8월 2024
Edgar (US Regulatory)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
11.472.863264511151.3458.2650.2127248553.33345482CS
4-2.18-3.9643571558554.9958.2650.2118837053.38707273CS
123.46.8811981380349.4158.2645.2427741651.17256297CS
2614.3137.168831168838.558.2637.5530131248.41389373CS
52-7.79-12.854785478560.664.9837.5535574249.00177303CS
15640.44326.91996766412.3764.984.2534426343.01168361CS
26040.44326.91996766412.3764.984.2534426343.01168361CS

MLTX - Frequently Asked Questions (FAQ)

What is the current MoonLake Immunotherapeut... share price?
The current share price of MoonLake Immunotherapeut... is US$ 52.81
How many MoonLake Immunotherapeut... shares are in issue?
MoonLake Immunotherapeut... has 63,905,198 shares in issue
What is the market cap of MoonLake Immunotherapeut...?
The market capitalisation of MoonLake Immunotherapeut... is USD 3.33B
What is the 1 year trading range for MoonLake Immunotherapeut... share price?
MoonLake Immunotherapeut... has traded in the range of US$ 37.55 to US$ 64.98 during the past year
What is the PE ratio of MoonLake Immunotherapeut...?
The price to earnings ratio of MoonLake Immunotherapeut... is -76.43
What is the reporting currency for MoonLake Immunotherapeut...?
MoonLake Immunotherapeut... reports financial results in USD
What is the latest annual profit for MoonLake Immunotherapeut...?
The latest annual profit of MoonLake Immunotherapeut... is USD -44.08M
What is the registered address of MoonLake Immunotherapeut...?
The registered address for MoonLake Immunotherapeut... is P.O. BOX 309, UGLAND HOUSE, GRAND CAYMAN, 1104
What is the MoonLake Immunotherapeut... website address?
The website address for MoonLake Immunotherapeut... is moonlaketx.com
Which industry sector does MoonLake Immunotherapeut... operate in?
MoonLake Immunotherapeut... operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
DRCTDirect Digital Holdings Inc
US$ 3.03
(450.91%)
38.31M
RELIReliance Global Group Inc
US$ 3.71
(209.17%)
96.02M
TRAWTraws Pharma Inc
US$ 12.10
(141.04%)
25.57M
RAPTRAPT Therapeutics Inc
US$ 1.7593
(113.15%)
116.49M
CHEKCheck Cap Ltd
US$ 1.2309
(108.63%)
3.69M
AILEiLearningEngines Inc
US$ 0.241599
(-72.70%)
13.74M
MGOLMGO Global Inc
US$ 0.4555
(-52.05%)
10.01M
YHCLQR House Inc
US$ 1.1489
(-34.35%)
1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.40915
(-33.10%)
128.71M
ADGMAdagio Medical Holdings Inc
US$ 1.115
(-32.42%)
4.28M
EDBLEdible Garden AG Inc
US$ 0.386
(62.39%)
369.59M
RGTIRigetti Computing Inc
US$ 11.02
(17.61%)
183.08M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.40915
(-33.10%)
131.77M
RAPTRAPT Therapeutics Inc
US$ 1.7593
(113.15%)
116.49M
RELIReliance Global Group Inc
US$ 3.71
(209.17%)
96.02M

MLTX Discussion

게시물 보기
Monksdream Monksdream 3 월 전
MLTX in an up trend
👍️0
AKATITUS AKATITUS 1 년 전
Sleeping
Come on 70.00
👍️0
Monksdream Monksdream 1 년 전
MLTX new 52 week high
👍️0
AKATITUS AKATITUS 1 년 전
Haha. Now that's funny. 18,000 share buy at 52.00 dollars.
👍️0
AKATITUS AKATITUS 1 년 전
Damm some big buys at 54.00 WoW
👍️0
AKATITUS AKATITUS 1 년 전
Hope it busts soon.
👍️0
AKATITUS AKATITUS 1 년 전
Looks like a good churning. Will tomorrow be the same. ??????
👍️0
MiamiGent MiamiGent 1 년 전
MLTX Started the day with a bang. Falling back, presently

MOONLAKE IMMUNOTHERAPEUTICS
$41.80 +15.92 (+61.51%)
As of Jun-26-202310:46:16 AM ET

https://stockcharts.com/h-sc/ui?s=MLTX

Wolfspeed, Genesco, PacWest Bancorp And Other Big Stocks Moving Higher On Monday
BENZINGA
31 mins ago
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Monday. Here are some big stocks recording gains in today's session.

MoonLake Immunotherapeutics (NASDAQ:MLTX) jumped 75% to $45.50 after the company's Phase 2 study for Nanobody sonelokimabint met its primary endpoint in hidradenitis suppurativa.

(con't)
👍️0
AKATITUS AKATITUS 1 년 전
So pissed I was trying to sell somethings to buy 40ts them boom 100 bucks F##########
👍️0
Awl416 Awl416 1 년 전
Crazy
👍️0
crudeoil24 crudeoil24 3 년 전
MoonLake Immunotherapeutics (NASDAQ: MLTX) 10% owner Bihua Chen acquired a total of 5,635,000 shares at an average price of $10.00. To acquire these shares, it cost around $28.5 million.
👍️0

최근 히스토리

NASDAQ
MLTX
MoonLake Immunotherapeut...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유